2024-12-08 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Report

**1. Performance Comparison & Overview:**

Colgate-Palmolive Co (CL) is a consumer goods company that manufactures and sells a wide range of personal care, home care, and pet nutrition products.

The cumulative return of CL (44.34%) significantly underperformed the S&P 500 (VOO) (122.19%) over the analyzed period.  The difference is -77.8%, placing it at the 1.8th percentile of its historical range against the S&P 500. This indicates consistent underperformance relative to the broader market.  The provided CAGR data shows fluctuating performance across different periods, with some years exceeding the market and others falling considerably short. The Alpha consistently sits around 0.2, suggesting a slight outperformance relative to the market’s beta adjusted returns, while the Beta remains relatively high around 0.5, indicating high market sensitivity.

**2. Recent Price Movement:**

* **Closing Price:** $94.23
* **5-Day Moving Average:** $95.17
* **20-Day Moving Average:** $94.23
* **60-Day Moving Average:** $97.65

The price is slightly below the 5-day moving average and very close to the 20-day moving average, suggesting potential consolidation.  The price is considerably below the 60-day moving average, indicating a recent downward trend.

**3. Technical Indicators & Expected Return:**

* **RSI:** 53.46 (Slightly above neutral; neither overbought nor oversold)
* **PPO:** 0.23 (Positive, suggesting bullish momentum)
* **20-Day Relative Strength Change:** -6.0% (Short-term bearish trend)
* **Expected Return:** 0.0% (The provided data does not support a meaningful prediction of long-term excess returns relative to the S&P 500 beyond two years.)

The current price of $94.22 does not indicate any significant recent sharp upward or downward movement.

**4. Recent Earnings Analysis:**

The provided earnings data shows a relatively stable revenue around $5B, with slight fluctuations. EPS has shown a generally upward trend, with a slight dip in Q2 2024 and Q3 2023.  Without access to expectations, it's impossible to determine whether results “beat” or “missed” estimates. However, based solely on the provided reported numbers, there is no clear trend of significant growth or decline.


**5. Financial Information Analysis:**

* **Revenue and Profitability:** Revenue remains relatively consistent around the $5 billion mark. Profit margins show a slight decline in recent quarters after peaking in 2024 Q1.

* **Capital and Profitability:** ROE fluctuates wildly, suggesting potential volatility in profitability and equity levels.  The significant negative ROE in 2023 Q3 is a major outlier requiring further investigation beyond the scope of this data.  This extreme variation needs to be explained, possibly by exceptional items not included in the simple statement.

**6. News and Recent Issues:**

No information on recent earnings news, market outlook, or analyst opinions is provided.  This section requires further information.


**7. Overall Analysis:**

Colgate-Palmolive (CL) shows mixed signals. While the company demonstrates relatively stable revenue and generally positive EPS trends, its significant underperformance compared to the S&P 500 is a major concern. The fluctuating ROE and the unexplained negative ROE in one quarter raise concerns about financial stability.  Technical indicators are neutral to slightly bullish, but the recent short-term downward trend suggests caution.  The lack of news and analyst data prevents a more comprehensive assessment.  Additional information is needed, particularly regarding the outlier in the ROE and the market context.

**8. Recommendations:**

Given the substantial underperformance relative to the S&P 500, the mixed financial indicators, and the absence of current market information, a thorough review of the company's long-term strategy, competitive landscape, and any significant one-time events is necessary before making an investment decision.  The high beta suggests significant market sensitivity, making it important to assess the overall market outlook before considering any investment. Further research, especially clarifying the extreme ROE fluctuation, is strongly recommended.
